XML 48 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net (loss) income $ (7,635,000) $ 2,667,000 $ (1,657,000)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities      
Depreciation 4,663,000 2,035,000 718,000
Amortization of intangible assets 8,202,000 3,033,000 1,079,000
Amortization of loan costs 121,000 0 0
Stock-based compensation 13,956,000 5,981,000 3,043,000
Non-cash lease expense 2,053,000 737,000 512,000
Gain on acquisition of SAVSU (6,451,000) 0 0
Deferred income tax benefit (20,127,000) (3,297,000) (1,541,000)
Change in fair value of contingent consideration 2,875,000 1,575,000 50,000
Change in fair value of warrant liability 121,000 (3,601,000) 12,835,000
Change in fair value of investments 0 (1,319,000) 0
Stock issued for services 0 60,000 0
Loss on disposal of assets held for rent, net 609,000 365,000 0
Loss on disposal of property and equipment, net 482,000 0 0
Forgiveness of loans payable (284,000) 0 0
Other 353,000 190,000 15,000
Change in operating assets and liabilities, net of effects of acquisitions      
Accounts receivable, trade, net (10,132,000) (1,786,000) (290,000)
Inventories 114,000 (629,000) (3,777,000)
Prepaid expenses and other current assets 2,802,000 25,000 (704,000)
Accounts payable 2,018,000 (171,000) 768,000
Accrued expenses and other current liabilities (3,936,000) 780,000 (327,000)
Warranty liability 5,833,000 0 0
Other (230,000) 0 (142,000)
Net cash (used in) provided by operating activities (4,593,000) 6,645,000 1,213,000
Cash flows from investing activities      
Purchases of property and equipment (8,385,000) (1,961,000) (675,000)
Deposits on property and equipment 0 (2,672,000) 0
Purchases of assets held for rent (6,371,000) (2,813,000) (1,655,000)
Deposits on assets held for rent 0 (362,000) 0
Proceeds from sale of equipment 5,000 35,000 0
Net cash used in investing activities (13,192,000) (24,715,000) (27,018,000)
Cash flows from financing activities      
Payments of contingent consideration 0 (483,000) 0
Proceeds from sale of common stock, net of $6.2 million of costs in 2020 0 100,121,000 0
Fees paid related to issuance of common stock (145,000) (6,200,000)  
Proceeds from line of credit 27,306,000 0 0
Payments on line of credit (31,536,000) 0 0
Proceeds from exercise of common stock options 1,418,000 1,472,000 1,181,000
Proceeds from exercise of warrants 0 40,000 574,000
Other (124,000) (56,000) (159,000)
Net cash (used in) provided by financing activities (2,778,000) 102,078,000 1,596,000
Net (decrease) increase in cash, cash equivalents, and restricted cash (20,563,000) 84,008,000 (24,209,000)
Cash, cash equivalents, and restricted cash – beginning of period 90,456,000 6,448,000 30,657,000
Effects of currency translation on cash, cash equivalents, and restricted cash (23,000) 0 0
Cash, cash equivalents, and restricted cash – end of period 69,870,000 90,456,000 6,448,000
Non-cash investing and financing activities      
Cashless exercise of warrants reclassified from warrant liability to common stock 2,901,000 33,111,000 0
Stock issued as consideration to acquire Global Cooling, Inc. and Sexton Biotechnologies, Inc. 264,718,000 0 0
Equipment acquired under operating leases 6,875,000 8,096,000 0
Equipment acquired under finance leases 440,000 0 0
Purchase of property and equipment not yet paid 197,000 0 29,000
Reclassification of warrant liabilities to equity upon exercise 0 110,000 1,749,000
Cash interest paid 452,000 0 0
Bonus Consideration [Member]      
Non-cash investing and financing activities      
Stock issued as bonus consideration 0 314,000 0
Paycheck Protection Program CARES Act [Member]      
Cash flows from financing activities      
Proceeds from Loan 0 2,175,000 0
Payoff of PPP Loan 0 (2,175,000) 0
Equipment Loans [Member]      
Cash flows from financing activities      
Proceeds from Loan 1,550,000 984,000 0
Payoff of PPP Loan (214,000) 0 0
Financed Insurance Premium [Member]      
Cash flows from financing activities      
Payments on financed insurance premium (1,033,000) 0 0
SAVSU [Member]      
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities      
Gain on acquisition of SAVSU 0 0 (10,108,000)
Cash flows from investing activities      
Cash acquired in acquisition 0 0 1,251,000
Non-cash investing and financing activities      
Stock issued as consideration to acquire Global Cooling, Inc. and Sexton Biotechnologies, Inc. 0 0 19,932,000
Astero [Member]      
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities      
Change in fair value of contingent consideration (81,000)    
Cash flows from investing activities      
Payments to Acquire Businesses, Net of Cash Acquired, Total 0 0 (12,439,000)
CBS Acquisition [Member]      
Cash flows from investing activities      
Payments to Acquire Businesses, Net of Cash Acquired, Total 0 0 (11,000,000)
Cash flows from financing activities      
Payments of contingent consideration 0 0  
Non-cash investing and financing activities      
Stock issued as consideration to acquire Global Cooling, Inc. and Sexton Biotechnologies, Inc. 0 0 4,000,000
SciSafe [Member]      
Cash flows from investing activities      
Payments to Acquire Businesses, Net of Cash Acquired, Total   (14,947,000) 0
Non-cash investing and financing activities      
Stock issued as consideration to acquire Global Cooling, Inc. and Sexton Biotechnologies, Inc. 0 17,916,000 0
Sexton Acquisition [Member]      
Cash flows from investing activities      
Cash acquired in acquisition 1,559,000    
SAVSU Investment [Member]      
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities      
Loss from equity method investment in SAVSU 0 0 739,000
Sexton Biotechnologies, Inc. [Member]      
Cash flows from investing activities      
Investment 0 0 (1,500,000)
IVexSol Convertible Debt Investment [Member]      
Cash flows from investing activities      
Investment in iVexSol convertible debt 0 0 (1,000,000)
IVexSol Preferred Stock Investment [Member]      
Cash flows from investing activities      
Investment 0 (1,000,000) 0
PanTHERA Cryosolutions Investment [Member]      
Cash flows from investing activities      
Investment $ 0 $ (995,000) $ 0